CEACAM1 and ovarian carcinoma: Kaplan–Meier analysis revealed a significant association of high CEACAM1 levels with a longer recurrence-free survival (p = 0.035) and overall survival (p = 0.004; Figure 2(b)) indicating that CEACAM1 might function as a tumor suppressor in ovarian carcinomas.